Pages that link to "Q41350341"
Jump to navigation
Jump to search
The following pages link to Felipe García (Q41350341):
Displaying 50 items.
- Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection (Q24536249) (← links)
- PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia (Q28551329) (← links)
- A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study (Q28743362) (← links)
- Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine. (Q31106756) (← links)
- [Indicator condition guided human immunodeficiency virus requesting in primary health care: results of a collaboration]. (Q33421199) (← links)
- Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression (Q33535953) (← links)
- Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards (Q33564972) (← links)
- Quinine induced lupus-like syndrome and cardiolipin antibodies. (Q33579165) (← links)
- Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections (Q33711805) (← links)
- Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation (Q34288534) (← links)
- Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals (Q34512293) (← links)
- Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal (Q34546056) (← links)
- Long-term CD4 T-cell response to highly active antiretroviral therapy according to baseline CD4 T-cell count (Q34548243) (← links)
- Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individuals (Q34630184) (← links)
- A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication (Q34646987) (← links)
- Lymphoid tissue collagen deposition in HIV-infected patients correlates with the imbalance between matrix metalloproteinases and their inhibitors (Q34764052) (← links)
- A therapeutic dendritic cell-based vaccine for HIV-1 infection (Q34764392) (← links)
- Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia (Q35077039) (← links)
- Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature (Q35105785) (← links)
- Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009. (Q35128754) (← links)
- Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses (Q35689037) (← links)
- Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection (Q35731394) (← links)
- HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses (Q35973632) (← links)
- MicroRNA Profile in CD8 T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression. (Q36015292) (← links)
- Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era. (Q36422552) (← links)
- Influence of episodes of intermittent viremia ("blips") on immune responses and viral load rebound in successfully treated HIV-infected patients. (Q36509570) (← links)
- The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial. (Q36580911) (← links)
- Rate and predictors of non-AIDS events in a cohort of HIV-infected patients with a CD4 T cell count above 500 cells/mm³. (Q37025746) (← links)
- Evolution of broadly cross-reactive HIV-1-neutralizing activity: therapy-associated decline, positive association with detectable viremia, and partial restoration of B-cell subpopulations (Q37254327) (← links)
- Immune modulators and treatment interruption. (Q37447549) (← links)
- Therapeutic vaccines against HIV infection (Q38013505) (← links)
- Dendritic cell based vaccines for HIV infection: the way ahead (Q38126373) (← links)
- Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation. (Q38296086) (← links)
- Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study (Q38402197) (← links)
- Rate and predictors of progression in elite and viremic HIV-1 controllers. (Q38409790) (← links)
- Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1. (Q38415577) (← links)
- Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. (Q38462726) (← links)
- Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02). (Q38484762) (← links)
- Early Detection Of Hiv Infection And Of Asymptomatic Sexually Transmitted Infections Among Men Who Have Sex With Men. (Q38607131) (← links)
- New challenges in therapeutic vaccines against HIV infection. (Q38692205) (← links)
- The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens. (Q38725610) (← links)
- Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients. (Q38738697) (← links)
- Standard vaccines increase HIV-1 transcription during antiretroviral therapy. (Q38840779) (← links)
- Utilization of healthcare services by people living with HIV/AIDS in Europe. Eurosupport Group. (Q38892546) (← links)
- Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial (Q39251042) (← links)
- Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study (Q39284131) (← links)
- Factors associated with the immune response to hepatitis A vaccination in HIV-infected patients in the era of highly active antiretroviral therapy. (Q39400490) (← links)
- A randomized clinical trial comparing ritonavir-boosted lopinavir versus maraviroc each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection (Q39905748) (← links)
- A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection (Q39905759) (← links)
- Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients (Q39984018) (← links)